Vascular Solutions (VASC) Tops Q1 EPS by 3c; Boosts FY15 EPS Outlok

Go back to Vascular Solutions (VASC) Tops Q1 EPS by 3c; Boosts FY15 EPS Outlok

Vascular Solutions Reports First Quarter Results

April 21, 2015 4:05 PM EDT

- Revenue increased 16% to $34.6 million, exceeding the top end of guidance - Adjusted EPS, excluding expenses associated with the Short Kit litigation, increased 18% to $0.21, exceeding the top end of guidance; GAAP EPS of $0.12 - Raising 2015 revenue guidance to $140-$144 million, representing an increase of 13% at the midpoint - Raising 2015 adjusted EPS guidance to $0.93-$0.97

MINNEAPOLIS, April 21, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq: VASC) today reported financial results for the first quarter ended March 31, 2015.

Worldwide... More